Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 18;9(3):2045894019841990.
doi: 10.1177/2045894019841990. Online ahead of print.

EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

Affiliations

EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

David G Kiely et al. Pulm Circ. .

Abstract

Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
PVRI diagnostic algorithm. In this algorithm, patients are classified into low, intermediate, and high risk of PH according to ESC/ERS guidelines. See section 3.2 for a detailed description of how to navigate the algorithm. *For patients with rapidly progressive symptoms and a high probability of PH on echocardiography do not delay referral to PH centre to complete imaging investigations. PH, pulmonary hypertension; PAH, pulmonary arterial hypertension; CTEPH, chronic thromboembolic pulmonary hypertension; ECG, electrocardiogram; DLco, diffusing capacity of the lungs for carbon monoxide; CXR, chest radiograph; CMRI, cardiac magnetic resonance imaging; CTPA, computed tomography pulmonary angiography; DECTA, dual-energy computed tomography angiography; CT-LISM, computed tomography lung iodine subtraction mapping; SPECT, single photon emission computed tomography; RV, right ventricular.

Similar articles

Cited by

References

    1. Kiely DG, Elliot CA, Sabroe I, et al. Pulmonary hypertension: diagnosis and management. BMJ 2013; 346: f2028. - PubMed
    1. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; ▪: ERJ–2015. - PubMed
    1. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed) 2016; 69: 177. - PubMed
    1. Hurdman J, Condliffe R, Elliot CA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. The European respiratory journal 2013; 41: 1292–1301. - PubMed
    1. Hurdman J, Condliffe R, Elliot CA, et al. Aspire Registry: assessing the spectrum of pulmonary hypertension identified at a referral centre. Eur Respir J 2011; ▪: ▪. - PubMed